Among the 42 BCBM samples, the distribution by tumor subtype according to the immunohistochemistry (IHC) included 42.9% TN, 26.2% ER+, 19.0% HER2+, and 11.9% ER+/HER2+ type (Table 1). The gene discussed is ERBB2; the disease is neoplasm.